{"id":"https://openalex.org/W1985259840","doi":"https://doi.org/10.1111/j.1365-2125.1979.tb04644.x","title":"Pharmacokinetics, pharmacology of atenolol and effect of renal disease.","display_name":"Pharmacokinetics, pharmacology of atenolol and effect of renal disease.","publication_year":1979,"publication_date":"1979-06-01","ids":{"openalex":"https://openalex.org/W1985259840","doi":"https://doi.org/10.1111/j.1365-2125.1979.tb04644.x","mag":"1985259840","pmid":"https://pubmed.ncbi.nlm.nih.gov/465278","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1429677"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2125.1979.tb04644.x","doi":"https://doi.org/10.1111/j.1365-2125.1979.tb04644.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.1979.tb04644.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1979.tb04644.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1979.tb04644.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108401838","display_name":"SH Wan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I1342924430","display_name":"LAC+USC Medical Center","ror":"https://ror.org/04xzj3x20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1328359107","https://openalex.org/I1342924430"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"SH Wan","raw_affiliation_strings":["The Schools of Pharmacy and Medicine, Section of Clinical Pharmacology, University of Southern California and the Los Angeles County/USC Medical Center, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Schools of Pharmacy and Medicine, Section of Clinical Pharmacology, University of Southern California and the Los Angeles County/USC Medical Center, Los Angeles, California","institution_ids":["https://openalex.org/I1174212","https://openalex.org/I1342924430"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109960943","display_name":"RT Koda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I1342924430","display_name":"LAC+USC Medical Center","ror":"https://ror.org/04xzj3x20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1328359107","https://openalex.org/I1342924430"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"RT Koda","raw_affiliation_strings":["The Schools of Pharmacy and Medicine, Section of Clinical Pharmacology, University of Southern California and the Los Angeles County/USC Medical Center, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Schools of Pharmacy and Medicine, Section of Clinical Pharmacology, University of Southern California and the Los Angeles County/USC Medical Center, Los Angeles, California","institution_ids":["https://openalex.org/I1174212","https://openalex.org/I1342924430"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111711593","display_name":"Robert F. Maronde","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I1342924430","display_name":"LAC+USC Medical Center","ror":"https://ror.org/04xzj3x20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1328359107","https://openalex.org/I1342924430"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"RF Maronde","raw_affiliation_strings":["The Schools of Pharmacy and Medicine, Section of Clinical Pharmacology, University of Southern California and the Los Angeles County/USC Medical Center, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Schools of Pharmacy and Medicine, Section of Clinical Pharmacology, University of Southern California and the Los Angeles County/USC Medical Center, Los Angeles, California","institution_ids":["https://openalex.org/I1174212","https://openalex.org/I1342924430"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":2.0487,"has_fulltext":true,"cited_by_count":50,"citation_normalized_percentile":{"value":0.8548219,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"7","issue":"6","first_page":"569","last_page":"574"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.6952999830245972,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.6952999830245972,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.2094999998807907,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.015300000086426735,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atenolol","display_name":"atenolol","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9760000109672546},{"id":"https://openalex.org/keywords/pharmacology","display_name":"pharmacology","score":0.6949999928474426},{"id":"https://openalex.org/keywords/kidney-failure","display_name":"renal failure","score":0.574999988079071},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.7760000228881836},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.8289999961853027},{"id":"https://openalex.org/keywords/oral-versus-intravenous-administration","display_name":"oral versus intravenous administration","score":0.7149999737739563},{"id":"https://openalex.org/keywords/saliva-drug-levels","display_name":"saliva drug levels","score":0.8159999847412109},{"id":"https://openalex.org/keywords/urinary-excretion","display_name":"urinary excretion","score":0.7289999723434448},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.796999990940094},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.5920000076293945},{"id":"https://openalex.org/keywords/blood-pressure-reduction","display_name":"blood pressure reduction","score":0.6359999775886536},{"id":"https://openalex.org/keywords/heart-rate-reduction","display_name":"heart rate reduction","score":0.9110000133514404}],"concepts":[{"id":"https://openalex.org/C2776525901","wikidata":"https://www.wikidata.org/wiki/Q411325","display_name":"Atenolol","level":3,"score":0.9742338061332703},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8967559337615967},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.67228102684021},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.6671978235244751},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5576439499855042},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.4450070559978485},{"id":"https://openalex.org/C504460877","wikidata":"https://www.wikidata.org/wiki/Q155925","display_name":"Saliva","level":2,"score":0.44443124532699585},{"id":"https://openalex.org/C3941253","wikidata":"https://www.wikidata.org/wiki/Q47270","display_name":"Half-life","level":3,"score":0.4327000379562378},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.31078386306762695},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2794160842895508}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001262","descriptor_name":"Atenolol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001262","descriptor_name":"Atenolol","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001262","descriptor_name":"Atenolol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003404","descriptor_name":"Creatinine","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007674","descriptor_name":"Kidney Diseases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011412","descriptor_name":"Propanolamines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1365-2125.1979.tb04644.x","doi":"https://doi.org/10.1111/j.1365-2125.1979.tb04644.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.1979.tb04644.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1979.tb04644.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1429677","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1429677","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},{"id":"pmid:465278","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/465278","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1365-2125.1979.tb04644.x","doi":"https://doi.org/10.1111/j.1365-2125.1979.tb04644.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.1979.tb04644.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1979.tb04644.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1985259840.pdf","grobid_xml":"https://content.openalex.org/works/W1985259840.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W80340148","https://openalex.org/W113908562","https://openalex.org/W167047154","https://openalex.org/W1480777276","https://openalex.org/W1975752614","https://openalex.org/W2052607561","https://openalex.org/W2061296115","https://openalex.org/W2062312481","https://openalex.org/W2076504401","https://openalex.org/W2094874940","https://openalex.org/W2309241413","https://openalex.org/W2336538006","https://openalex.org/W2401921565","https://openalex.org/W2403055301","https://openalex.org/W2417113860","https://openalex.org/W2464952116","https://openalex.org/W6604607496"],"related_works":["https://openalex.org/W2086821723","https://openalex.org/W2076085396","https://openalex.org/W2055816301","https://openalex.org/W2061296115","https://openalex.org/W2010594349","https://openalex.org/W2079443574","https://openalex.org/W80340148","https://openalex.org/W21315727","https://openalex.org/W2398502684","https://openalex.org/W2031232550"],"abstract_inverted_index":{"1.":[0],"The":[1],"pharmacokinetics":[2,73,86],"of":[3,45,76,104],"intravenous":[4],"and":[5,18,74,94],"oral":[6],"atenolol":[7,36,49,77,117],"(50":[8],"mg)":[9],"in":[10,35,55,80,90,123],"six":[11],"healthy":[12,82],"volunteers":[13],"was":[14,31,50,78,129],"studied.":[15],"Plasma,":[16],"saliva":[17,56],"urine":[19],"were":[20,87,98],"collected":[21],"up":[22],"to":[23,61,100],"24":[24],"h":[25,60],"after":[26],"each":[27],"dose.":[28],"2.":[29],"There":[30],"no":[32],"significant":[33],"difference":[34],"half-life":[37,122],"when":[38],"administered":[39,48],"by":[40],"the":[41,46,72,102,109],"two":[42],"routes.":[43],"Bioavailability":[44],"orally":[47],"50%.":[51],"3.":[52],"Atenolol":[53],"levels":[54],"required":[57],"about":[58],"2":[59],"reach":[62],"equilibrium":[63],"with":[64,126],"plasma":[65,110],"drug":[66],"levels.":[67],"4.":[68],"A":[69],"comparison":[70],"between":[71],"pharmacology":[75],"made":[79],"twelve":[81],"subjects.":[83],"5.":[84],"Dose-independent":[85],"observed.":[88],"Reductions":[89],"resting":[91],"heart":[92],"rate":[93],"arterial":[95],"blood":[96],"pressure":[97],"proportional":[99],"either":[101],"logarithm":[103],"dose":[105],"or":[106,114],"area":[107],"under":[108],"concentration":[111],"time":[112],"curve":[113],"cumulative":[115],"urinary":[116],"excretion.":[118],"6.":[119],"Plasma":[120],"elimination":[121],"five":[124],"subjects":[125],"renal":[127],"failure":[128],"prolonged.":[130]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}